Specific

alpha-1-fetoprotein (AFP) [Multiple of the median, MOM] adjusted in amniotic fluid alpha-1-fetoprotein (AFP) [Multiple of the median, MOM] adjusted in serum/plasma appearance of tissue bacterial vaginosis interpretation in vaginal fluid body iron distribution/stores Borrelia burgdorferi antibody in serum interpretation calcium, corrected in serum cardiac index cholesterol LDL in serum calculated cholesterol VLDL in serum calculated choriogonadotropin beta [Multiple of the median] (MOM) adjusted in serum/plasma choriogonadotropin [Multiple of the median] (MOM) adjusted in amniotic fluid choriogonadotropin [Multiple of the median] (MOM) adjusted in serum/plasma chromosome analysis overall interpretation color of stone composition of stone creatine kinase isozymes crystals in specimen cytology report of cervical or vaginal smear delivery date estimated diagnostic impression by molecular genetics early to atrial ratio (E/A ratio) estimated average glucose (eAG, glucose mean value in blood) estriol unconjugated [Multiple of the median] (MOM) adjusted in amniotic fluid estriol unconjugated [Multiple of the median] (MOM) adjusted in serum first & fecond trimester integrated maternal screen interpretation First trimester maternal screen with nuchal translucency glomerular filtration rate (GFR) IgG index in serum & CSF IgG synthesis rate in serum & CSF laboratory evaluation of Alzheimer's disease LDL density pattern in serum leukocyte morphology in blood lipid risk factors lipoprotein insulin resistance score lipoprotein pattern in blood Lowry assay macroscopic examination morphology in blood myeloid:erythroid ratio neural tube defect risk in fetus nidus in stone oxygen arterial-venous in blood oxygen capacity in arterial blood pathologist review pathology report comments pathology report final diagnosis pathology report gross observation (gross description) pathology report microscopic observation (microscopic description) pathology report preliminary diagnosis pathology report supplemental reports pleural fluid analysis prostate-specific antigen (PSA) velocity recommended follow-up in cervical or vaginal smear second trimester maternal screen second trimester quad maternal screen interpretation size of stone statement of adequacy of cervical or vaginal smear stool osmolal gap trisomy 13 + trisomy 18 risk in fetus trisomy 13 risk in fetus trisomy 13+18+21 risk in fetus trisomy 18 + trisomy 21 risk in fetus trisomy 18 risk in fetus trisomy 21 risk in fetus urine sediment comments